Biotech Bearish Stocks: Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Corcept Therapeutics Incorporated (NASDAQ:CORT), Puma Biotechnology Inc (NYSE:PBYI), Conatus Pharmaceuticals (NASDAQ:CNAT)

A Palo Alto startup will focus an $18 million VC investment on developing a drug to stop unexplained recurrent miscarriages. Nora Therapeutics is capitalizing on work started by cofounder Darryl Carter at Johns Hopkins University that led to development of Nora’s lead drug, NT-100. Nora is led by CEO Jeff Tong, who had been vice president of corporate and product development at Infinity Pharmaceuticals Inc. … Continue reading Biotech Bearish Stocks: Infinity Pharmaceuticals Inc. (NASDAQ:INFI), Corcept Therapeutics Incorporated (NASDAQ:CORT), Puma Biotechnology Inc (NYSE:PBYI), Conatus Pharmaceuticals (NASDAQ:CNAT)

Hot Stocks: FireEye Inc (NASDAQ:FEYE), Synageva BioPharma Corp (NASDAQ:GEVA), Intrexon Corp (NYSE:XON), Puma Biotechnology Inc (NYSE:PBYI)

FireEye, Inc. (NASDAQ: FEYE) filed a registration with the U.S. SEC to sell, from time to time, up to 13,282,316 shares of its Common Stock on behalf of Selling Shareholders. FireEye Inc (NASDAQ:FEYE) stock performance was 5.05% in last session and finished the day at $50.57. Traded volume was 6.04million shares in the last session and the average volume of the stock remained 3.61million shares. … Continue reading Hot Stocks: FireEye Inc (NASDAQ:FEYE), Synageva BioPharma Corp (NASDAQ:GEVA), Intrexon Corp (NYSE:XON), Puma Biotechnology Inc (NYSE:PBYI)

Aastrom Biosciences Inc (NASDAQ:ASTM) posted its quarterly earnings results on Thursday. The company reported ($1.26) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.92) by $0.34, AnalystRatings.NET reports. On a related note, analysts at Zacks reiterated a “neutral” rating on shares of the company in a research note on Friday, March 14th. They now have a $5.00 price target on the … Continue reading Biotech Volatile Stocks: Aastrom Biosciences Inc (NASDAQ:ASTM), Puma Biotechnology Inc (NYSE:PBYI), Oncolytics Biotech (NASDAQ:ONCY), Clovis Oncology (NASDAQ:CLVS), Idenix Pharmaceuticals (NASDAQ:IDIX)